The growth in the forecast period can be attributed to expanding obesity management indications, increasing demand for effective weight loss drugs, growing awareness of cardiometabolic benefits, pipeline expansion of next-generation glp-1 therapies, rising healthcare focus on preventive metabolic care
Medical experts told the New York Post that there could be several reasons for these changes, including: Suppressed dopamine systems Lack of proper nutrients due to reduced hunger Losing eating as a stress coping mechanism Disappointment with quality of life after weight loss The New York Post also pointed out that drugs advertised for weight loss, like Wegovy and Saxenda, are required to warn users about the possibility of suicidal thoughts
Step 1: Getting Started Is Easier Than You Think Starting a new weight loss journey can feel intimidating, especially when the process feels complicated right from the beginning
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test analyzes four key variants (GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, MC4R rs17782313) that predispose individuals to varying levels of responsiveness across the GLP-1 and GIP signaling pathways